Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a ...

One in six laboratory-confirmed bacteria in 2023 proved resistant to antibiotic treatment, according to the World Health ...

Innoviva’s zoliflodacin is a first-in-class, single-dose, oral spiropyrimidinetrione antibiotic currently under regulatory ...

Data highlighting potential of Nu-3 in mildly infected diabetic foot ulcer (iDFU) published in "Antimicrobial Agents and ...

Zoliflodacin, an investigational single-dose oral antibiotic for uncomplicated gonorrhea, to be featured in oral presentation ...

Honeybees, those tireless foragers, carry much more than just pollen when they visit flowers. Their precious harvests ...

It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common ...

According to reports, Zaynich merges cefepime (a cephalosporin antibiotic) with zidebactam (a beta-lactamase inhibitor/enhancer), giving it a dual mechanism of action that promises to overcome some of ...

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs ...

The market for pyelonephritis treatments presents opportunities in novel drug development, emphasizing advanced ESBL coverage and efficacy under acidic conditions. Key players include Wockhardt and ...

Jon Stokes’s research lab has discovered what could be a breakthrough treatment for Crohn’s and inflammatory bowel disease in about 100 seconds. Rather, his AI sequencing tool discovered it in 100 ...

They are uncomfortable, annoying and occasionally dangerous. But fevers are also an essential part of how we protect ...